A treatment algorithm for Lambert-Eaton myasthenic syndrome.
Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Headington, United Kingdom.
J
J
Newsom-Davis
D015761:4-Aminopyridine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000465:Algorithms; D000077770:Amifampridine; D001379:Azathioprine / Q000627:therapeutic use; D018288:Carcinoma, Small Cell / Q000150:complications / Q000628:therapy; D002985:Clinical Protocols; D006801:Humans; D015624:Lambert-Eaton Myasthenic Syndrome / Q000150:complications / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D008175:Lung Neoplasms / Q000150:complications / Q000628:therapy; D015221:Potassium Channels; D011239:Prednisolone / Q000627:therapeutic use
D015221:Potassium Channels; D011239:Prednisolone; D015761:4-Aminopyridine; D001379:Azathioprine; D000077770:Amifampridine